date:Jul 25, 2014
administrative process and likely litigation.
Chief Judge Robert Katzmann dissented. He said the decision lets the FDA openly declare that a particular animal drug is unsafe, but then refuse to withdraw approval, and effectively ignore challenges to that policy. I do not believe the statutory scheme can be read to permit those results.
Jennifer Sorenson, a lawyer for the NRDC, said the decision effectively gives the FDA a free pass to ignore the science when it is politically inconvenient. Sh